[Clinical evaluation of clindamycin (7-chlorolincomycin) in the urological field].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D003556:Cystitis / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006027:Glycosides / Q000627:therapeutic use; D006801:Humans; D006869:Hydronephrosis / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011511:Proteus / Q000187:drug effects; D011702:Pyelitis / Q000188:drug therapy; D011759:Pyrrolidines / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D013210:Staphylococcus / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy; D014570:Urologic Diseases / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D006027:Glycosides; D011759:Pyrrolidines